HealthEU-Startupsabout 1 hour ago
Magnitude Biosciences Secures €1.5M for Drug Discovery
1 min read
Magnitude Biosciences, a Durham University spinout and contract research organisation, has secured €1.5 million in funding. The investment will accelerate the commercialisation of VivoScan, its proprietary in vivo high-throughput screening platform for drug discovery.
Level
Hype check
Tap to vote and see what everyone thinks.
